93.70

3.53% -3.4502

Zimmer Biomet Holdings Inc (ZBH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$97.15

Aprire:

$96.17

Volume 24 ore:

490.11K

Relative Volume:

0.20

Capitalizzazione di mercato:

$18.11B

Reddito:

$8.41B

Utile/perdita netta:

$760.80M

Rapporto P/E:

24.33

EPS:

3.8513

Flusso di cassa netto:

$1.05B

1 W Prestazione:

+4.55%

1M Prestazione:

+8.87%

6M Prestazione:

+7.64%

1 anno Prestazione:

+0.43%

Intervallo 1D:

$93.49

$96.47

Intervallo di 1 settimana:

$90.43

$97.60

Portata 52W:

$79.12

$108.29

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Nome

Zimmer Biomet Holdings Inc

Settore

Healthcare (1080)

Industria

Medical Devices (140)

Telefono

(574) 267-6131

Indirizzo

345 EAST MAIN STREET, WARSAW, IN

Dipendente

17,000

Cinguettio

@zimmerbiomet

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

ZBH's Discussions on Twitter

Compare ZBH vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ZBH Zimmer Biomet Holdings Inc	93.62	17.81B	8.41B	760.80M	1.05B	3.8513
ABT Abbott Laboratories	105.09	182.00B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	345.56	129.09B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	85.45	107.81B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	45.09	67.64B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.86	47.81B	6.30B	1.07B	1.09B	1.8406

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-23	Downgrade	BTIG Research	Buy → Neutral
2026-02-20	Iniziato	William Blair	Mkt Perform
2026-01-09	Downgrade	Goldman	Neutral → Sell
2026-01-06	Downgrade	Raymond James	Outperform → Mkt Perform
2026-01-05	Aggiornamento	Evercore ISI	In-line → Outperform
2025-12-16	Downgrade	Robert W. Baird	Outperform → Neutral
2025-11-06	Downgrade	JP Morgan	Overweight → Neutral
2025-09-18	Iniziato	Rothschild & Co Redburn	Buy
2025-07-15	Aggiornamento	Roth Capital	Neutral → Buy
2024-12-17	Aggiornamento	JP Morgan	Neutral → Overweight
2024-09-10	Iniziato	Wolfe Research	Peer Perform
2024-07-01	Downgrade	Piper Sandler	Overweight → Neutral
2024-05-30	Iniziato	Goldman	Neutral
2024-05-21	Aggiornamento	Argus	Hold → Buy
2024-01-04	Downgrade	Evercore ISI	Outperform → In-line
2023-10-20	Iniziato	ROTH MKM	Neutral
2023-08-28	Aggiornamento	BTIG Research	Neutral → Buy
2023-05-03	Aggiornamento	BofA Securities	Underperform → Neutral
2023-04-11	Aggiornamento	Evercore ISI	In-line → Outperform
2023-03-31	Aggiornamento	Jefferies	Underperform → Hold
2023-03-29	Iniziato	UBS	Sell
2023-03-10	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-01-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-01-05	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-01-03	Downgrade	Evercore ISI	Outperform → In-line
2022-11-23	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-10-18	Iniziato	Barclays	Underweight
2022-10-12	Iniziato	Jefferies	Underperform
2022-05-27	Downgrade	Needham	Buy → Hold
2022-04-13	Downgrade	Truist	Buy → Hold
2022-04-01	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Underperform
2022-03-02	Downgrade	Loop Capital	Buy → Hold
2022-02-08	Downgrade	Canaccord Genuity	Buy → Hold
2022-02-08	Reiterato	Citigroup	Buy
2022-02-08	Reiterato	Deutsche Bank	Hold
2022-02-08	Reiterato	JMP Securities	Mkt Outperform
2022-02-08	Reiterato	JP Morgan	Neutral
2022-02-08	Reiterato	RBC Capital Mkts	Sector Perform
2022-02-08	Reiterato	Stifel	Buy
2022-02-08	Reiterato	Truist	Buy
2022-02-08	Reiterato	UBS	Neutral
2022-02-08	Reiterato	Wells Fargo	Underweight
2022-02-02	Downgrade	UBS	Buy → Neutral
2022-01-19	Downgrade	Wells Fargo	Equal Weight → Underweight
2022-01-10	Downgrade	Mizuho	Buy → Neutral
2022-01-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Downgrade	Piper Sandler	Overweight → Neutral
2021-12-10	Iniziato	RBC Capital Mkts	Sector Perform
2021-12-09	Downgrade	Needham	Strong Buy → Buy
2021-12-07	Iniziato	Loop Capital	Buy
2021-11-23	Downgrade	Argus	Buy → Hold
2021-09-14	Ripresa	Raymond James	Mkt Perform
2021-05-25	Iniziato	Barclays	Overweight
2021-04-09	Aggiornamento	Northland Capital	Market Perform → Outperform
2021-01-04	Aggiornamento	Evercore ISI	In-line → Outperform
2020-12-18	Reiterato	Needham	Strong Buy
2020-10-20	Iniziato	Northland Capital	Market Perform
2020-09-11	Iniziato	Wolfe Research	Outperform
2020-08-05	Reiterato	Needham	Strong Buy
2020-04-28	Downgrade	Guggenheim	Buy → Neutral
2020-04-09	Downgrade	Evercore ISI	Outperform → In-line
2020-04-07	Reiterato	Needham	Strong Buy
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Buy
2020-01-08	Iniziato	SunTrust	Buy
2020-01-07	Aggiornamento	Piper Jaffray	Neutral → Overweight
2020-01-07	Aggiornamento	Piper Sandler	Neutral → Overweight
2019-12-04	Aggiornamento	Raymond James	Outperform → Strong Buy
2019-10-07	Aggiornamento	BTIG Research	Neutral → Buy
2019-09-18	Aggiornamento	Canaccord Genuity	Hold → Buy
2019-08-12	Aggiornamento	Argus	Hold → Buy
2019-07-30	Aggiornamento	Barclays	Underweight → Equal Weight
2019-07-29	Aggiornamento	Robert W. Baird	Neutral → Outperform
2019-06-11	Aggiornamento	Bernstein	Underperform → Mkt Perform
2019-04-24	Aggiornamento	Needham	Buy → Strong Buy

Mostra tutto

Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie

Jul 28, 2026

UBS Upgrades Zimmer Biomet Holdings to Buy From Sell, Adjusts Price Target to $115 From $89 - marketscreener.com

Jul 28, 2026

UBS initiates Zimmer Biomet stock coverage with buy rating By Investing.com - Investing.com Australia

Jul 28, 2026

Jul 27, 2026

Q1 Surgical Equipment & ConsumablesDiversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks - Yahoo Finance

Jul 27, 2026

Jul 26, 2026